Additional file 2 of FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments

Autor: Kaniyappan, Senthilvelrajan, Tepper, Katharina, Biernat, Jacek, Chandupatla, Ram Reddy, Hübschmann, Sabrina, Irsen, Stephan, Bicher, Sandra, Klatt, Christoph, Eva-Maria Mandelkow, Mandelkow, Eckhard

Additional file 2 Figure S1. GFP-TauFL-wt promotes assembly of microtubules in vitro. (a) Microtubules (10 μM) assembled in vitro in presence of untagged TauFL-wt (5 μM) or (b) GFP-TauFL-wt (10 μM) were imaged by negative stain electron microscopy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b17cfb025fc880251da72baf4c64ff8

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Altering glycopeptide antibiotic biosynthesis through mutasynthesis allows incorporation of fluorinated phenylglycine residues.

Autor: Voitsekhovskaia I; Microbial Bioactive Compounds, Interfaculty Institute of Microbiology and Infection Medicine Tübingen, University of Tübingen Tübingen Germany evi.stegmann@uni-tuebingen.de., Ho YTC; Department of Biochemistry and Molecular Biology, The Monash Biomedicine Discovery Institute, Monash University Clayton VIC 3800 Australia max.cryle@monash.edu.; EMBL Australia, Monash University Clayton VIC 3800 Australia.; ARC Centre of Excellence for Innovations in Peptide and Protein Science Australia., Klatt C; Institute of Organic Chemistry, University of Tübingen Tübingen Germany., Müller A; Institute for Pharmaceutical Microbiology, University Hospital Bonn, University of Bonn Bonn Germany., Machell DL; Department of Biochemistry and Molecular Biology, The Monash Biomedicine Discovery Institute, Monash University Clayton VIC 3800 Australia max.cryle@monash.edu.; EMBL Australia, Monash University Clayton VIC 3800 Australia.; ARC Centre of Excellence for Innovations in Peptide and Protein Science Australia., Tan YJ; ARC Centre of Excellence for Innovations in Peptide and Protein Science Australia.; Research School of Chemistry, The Australian National University Acton ACT 2601 Australia., Triesman M; Department of Biochemistry and Molecular Biology, The Monash Biomedicine Discovery Institute, Monash University Clayton VIC 3800 Australia max.cryle@monash.edu.; EMBL Australia, Monash University Clayton VIC 3800 Australia.; ARC Centre of Excellence for Innovations in Peptide and Protein Science Australia., Bingel M; Institute for Pharmaceutical Microbiology, University Hospital Bonn, University of Bonn Bonn Germany., Schittenhelm RB; Monash Proteomics and Metabolomics Platform, Monash University Clayton VIC 3800 Australia., Tailhades J; Department of Biochemistry and Molecular Biology, The Monash Biomedicine Discovery Institute, Monash University Clayton VIC 3800 Australia max.cryle@monash.edu.; EMBL Australia, Monash University Clayton VIC 3800 Australia.; ARC Centre of Excellence for Innovations in Peptide and Protein Science Australia., Kulik A; Microbial Bioactive Compounds, Interfaculty Institute of Microbiology and Infection Medicine Tübingen, University of Tübingen Tübingen Germany evi.stegmann@uni-tuebingen.de., Maier ME; Institute of Organic Chemistry, University of Tübingen Tübingen Germany., Otting G; ARC Centre of Excellence for Innovations in Peptide and Protein Science Australia.; Research School of Chemistry, The Australian National University Acton ACT 2601 Australia., Wohlleben W; Microbiology/Biotechnology, Interfaculty Institute of Microbiology and Infection Medicine Tübingen, University of Tübingen Tübingen Germany., Schneider T; Institute of Organic Chemistry, University of Tübingen Tübingen Germany.; Institute for Pharmaceutical Microbiology, University Hospital Bonn, University of Bonn Bonn Germany., Cryle M; Department of Biochemistry and Molecular Biology, The Monash Biomedicine Discovery Institute, Monash University Clayton VIC 3800 Australia max.cryle@monash.edu.; EMBL Australia, Monash University Clayton VIC 3800 Australia.; ARC Centre of Excellence for Innovations in Peptide and Protein Science Australia., Stegmann E; Microbial Bioactive Compounds, Interfaculty Institute of Microbiology and Infection Medicine Tübingen, University of Tübingen Tübingen Germany evi.stegmann@uni-tuebingen.de.; ARC Centre of Excellence for Innovations in Peptide and Protein Science Australia.; German Centre for Infection Research (DZIF), Partner Site Tübingen Tübingen Germany.; Cluster of Excellence 'Controlling Microbes to Fight Infections' (CMFI), University of Tübingen Tübingen Germany.

Publikováno v: RSC chemical biology [RSC Chem Biol] 2024 Aug 12. Date of Electronic Publication: 2024 Aug 12.